Increase your brand’s visibility and awareness in the region.
The precision medicine market size in MEA is estimated to be USD 7.65 billion by 2026
The precision medicine market size in MEA is estimated to be USD 7.65 billion by 2026.
The Middle East and Africa precision market is expected to be driven by increased adoption of gene therapy across the region and increased use of big data analytics in precision medicine. Growing demand for preventive care and substantial changes in the field of gene therapy, rise in the demand for gene therapy to treat major chronic illnesses and cancer, increased R&D for selecting the most effective treatment based on preclinical research and tumor molecular analysis will contribute to the expansion of this market.
Who can sponsor?
- Pharmaceuticals and biotech companies,
- Clinical laboratories,
- Diagnostic companies
- Healthcare IT specialists
- Big data companies